Overview

Alternate-Day Buprenorphine. Phase V - 6

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate buprenorphine blockade challenge.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
University of Vermont
Treatments:
Buprenorphine